JPRN-UMIN000018118已完成未知
The efficacy of ferric citrate hydrate in chronic kidney disease with mild hyperphosphatemia: randomized controlled open-labeled trial - FC CKD study
Osaka Medical College, department of Internal Medicine 30 个研究点目标入组 40 人开始时间: 2015年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)impossible dose of ferric citrate hydrate 2)already medicated by other phsphate binders 3)patients participating in other clinical intervention trial 4)presence of severe complication 5)Physician's decision
研究者
相似试验
招募中
Unknown
Efficacy of ferric citrate hydrate in chronic heart failure complicated with iron deficiency anaemia.chronic heart failure with Iron deficiency anaemiaJPRN-UMIN000050436Sekino Hospital100
已完成
不适用
Clinical evaluation of the effect of ferric citrate hydrate in hemodialysis patients with renal anemia and hyperphosphatemiaJPRN-UMIN000025478Saiseikai Kumamoto Hospital80
已完成
不适用
Effects and safety of ferric citrate hydrate in patients with receiving hemodialysis.Chronic hemodialysis patientsJPRN-UMIN000028669Tomei-Atsugi Hospital30
已完成
不适用
A prospective study for the effect of ferric citrate on FGF23 in patients with normophosphatemic CKD patients with iron deficiency.chronic kidney diseaseJPRN-UMIN000020935Department of Nephrology and Rheumatology, Saiseikai Niigata Daini Hospital60
招募中
不适用
Effect of ferric citrate for recovery from fatigue, phosphate binding, and iron supplementation in hemodialysis patients with well-controlled parathyroid hormone. -comparison with lanthanum carbonatehemodialysis patientsJPRN-UMIN000039788Ishikiri Seiki Hospital60